Get the Stockscreener App
0.14
6.06%
0.008
INNOCAN PHARMA CORP. Stock (INNPF) Forecast
The INNOCAN PHARMA CORP. (INNPF) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.4559, representing a +939.92% increase from the current price of $0.14. The highest analyst price target is $1.8403, and the lowest is $1.0715.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month INNPF Price Target
Average 1.7721
(+1,166% Upside)
Long-term INNPF price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about INNOCAN PHARMA CORP. financial reports and earnings history, INNOCAN PHARMA CORP. (INNPF) stock could reach $5.6347 by 2030, $13.86 by 2040 and $21.07 by 2050. See the projected annual prices until 2050 of the INNOCAN PHARMA CORP. stock below:
- INNOCAN PHARMA CORP. (INNPF) is expected to reach an average price of $8.8895 in 2035, with a high prediction of $9.7453 and a low estimate of $5.9617. This indicates an $6,250% rise from the last recorded price of $0.14.
- INNOCAN PHARMA CORP. (INNPF) stock is projected to chart a bullish course in 2040, with an average price target of $12.09, representing an $8,536% surge from its current level. The forecast ranges from a conservative $8.5046 to a sky-high $13.86.
- Our analysts predict INNOCAN PHARMA CORP. (INNPF) to jump 10,543% by 2045, soaring from $14.92 to an average price of $14.90, potentially reaching $17.97. While $14.92 is the low estimate, the potential upside is significant.
- INNOCAN PHARMA CORP. (INNPF) stock is expected to climb by 2050, reaching an average of $18.31, a $12,981% jump from its current level. However, a wide range of estimates exists, with high and low targets of $21.07 and $18.33, respectively, highlighting the market's uncertainty.
INNOCAN PHARMA CORP. Stock (INNPF) Year by Year Forecast
INNOCAN PHARMA CORP. Stock (INNPF) Price Forecast for 2025
INNOCAN PHARMA CORP. Stock (INNPF) is expected to reach an average price of $1.5162 in 2025, with a high prediction of $2.1565 and a low estimate of $0.8759. This indicates an +982.98% rise from the last recorded price of $0.14.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2025 | $1.7037 | $1.0715 | $1.8403 | +1,117% |
| July, 2025 | $1.4409 | $1.4791 | $1.6514 | +929.25% |
| August, 2025 | $1.9984 | $1.1693 | $1.9984 | +1,327% |
| September, 2025 | $1.6053 | $1.6053 | $1.8402 | +1,047% |
| October, 2025 | $1.3913 | $1.2671 | $1.5156 | +893.80% |
| November, 2025 | $1.878 | $1.878 | $2.1565 | +1,241% |
| December, 2025 | $1.4635 | $1.4656 | $1.7699 | +945.37% |
INNOCAN PHARMA CORP. Stock (INNPF) Price Forecast for 2026
The predicted value for INNOCAN PHARMA CORP. (INNPF) in 2026 is set at an average of $2.235. Estimates vary from a peak of $3.1051 to a trough of $1.3649, indicating an +1,496% surge from the present price of $0.14.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.0885 | $1.3649 | $2.3146 | +1,392% |
| February, 2026 | $1.7947 | $1.8329 | $2.016 | +1,182% |
| March, 2026 | $2.3093 | $1.4627 | $2.4727 | +1,550% |
| April, 2026 | $1.9792 | $1.9792 | $2.2302 | +1,314% |
| May, 2026 | $1.7149 | $1.5605 | $1.8693 | +1,125% |
| June, 2026 | $2.1638 | $2.1795 | $2.6308 | +1,446% |
| July, 2026 | $1.777 | $1.7791 | $2.068 | +1,169% |
| August, 2026 | $2.5226 | $1.6583 | $2.7889 | +1,702% |
| September, 2026 | $1.9785 | $1.9896 | $2.43 | +1,313% |
| October, 2026 | $2.7635 | $1.7561 | $2.947 | +1,874% |
| November, 2026 | $2.353 | $2.353 | $2.6643 | +1,581% |
| December, 2026 | $3.1051 | $1.8539 | $3.1051 | +2,118% |
INNOCAN PHARMA CORP. Stock (INNPF) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for INNOCAN PHARMA CORP. (INNPF) is $2.9237, with a high forecast of $3.8956 and a low forecast of $1.9517. This indicates an +1,988% increase from the last price of $0.14.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.5577 | $2.5734 | $2.90 | +1,727% |
| February, 2027 | $2.0905 | $2.0926 | $2.4418 | +1,393% |
| March, 2027 | $2.844 | $1.9517 | $3.2632 | +1,931% |
| April, 2027 | $2.3121 | $2.3232 | $2.6891 | +1,551% |
| May, 2027 | $3.2177 | $2.0495 | $3.4213 | +2,198% |
| June, 2027 | $2.62 | $2.6582 | $3.0984 | +1,771% |
| July, 2027 | $3.5794 | $2.1473 | $3.5794 | +2,457% |
| August, 2027 | $2.8514 | $2.8514 | $3.3542 | +1,937% |
| September, 2027 | $2.4699 | $2.2451 | $2.6946 | +1,664% |
| October, 2027 | $3.258 | $3.258 | $3.7375 | +2,227% |
| November, 2027 | $2.5086 | $2.5107 | $3.083 | +1,692% |
| December, 2027 | $3.5355 | $2.3429 | $3.8956 | +2,425% |
INNOCAN PHARMA CORP. Stock (INNPF) Price Forecast for 2028
In 2028, INNOCAN PHARMA CORP. (INNPF) is projected to reach an average price of $3.5634, with a high projection of $4.6861 and a low estimate of $2.4407. This indicates an +2,445% rise from the last price of $0.14.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.9737 | $3.0119 | $3.396 | +2,024% |
| February, 2028 | $3.8233 | $2.4407 | $4.0537 | +2,631% |
| March, 2028 | $3.2252 | $3.2252 | $3.6772 | +2,204% |
| April, 2028 | $2.7934 | $2.5385 | $3.0483 | +1,895% |
| May, 2028 | $3.4769 | $3.4926 | $4.2118 | +2,383% |
| June, 2028 | $2.8221 | $2.8242 | $3.314 | +1,916% |
| July, 2028 | $3.9696 | $2.6363 | $4.3699 | +2,735% |
| August, 2028 | $3.0905 | $3.1016 | $3.8101 | +2,108% |
| September, 2028 | $4.2775 | $2.7342 | $4.528 | +2,955% |
| October, 2028 | $3.4453 | $3.4835 | $4.1113 | +2,361% |
| November, 2028 | $4.6861 | $2.832 | $4.6861 | +3,247% |
| December, 2028 | $3.8708 | $3.8865 | $4.414 | +2,665% |
INNOCAN PHARMA CORP. Stock (INNPF) Price Forecast for 2029
The 2029 price forecast for INNOCAN PHARMA CORP. Stock (INNPF) is $4.2032 on average, with a high prediction of $5.4766 and a low estimate of $2.9298. This represents an +2,902% increase from the previous price of $0.14.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $3.3088 | $2.9298 | $3.6878 | +2,263% |
| February, 2029 | $4.2241 | $4.2241 | $4.8442 | +2,917% |
| March, 2029 | $3.4241 | $3.4352 | $4.0021 | +2,346% |
| April, 2029 | $4.7317 | $3.0276 | $5.0023 | +3,280% |
| May, 2029 | $3.799 | $3.8372 | $4.5454 | +2,614% |
| June, 2029 | $5.1604 | $3.1254 | $5.1604 | +3,586% |
| July, 2029 | $4.0974 | $4.0974 | $4.8682 | +2,827% |
| August, 2029 | $3.5484 | $3.2232 | $3.8736 | +2,435% |
| September, 2029 | $4.6381 | $4.6381 | $5.3185 | +3,213% |
| October, 2029 | $3.5536 | $3.5557 | $4.396 | +2,438% |
| November, 2029 | $4.9825 | $3.321 | $5.4766 | +3,459% |
| December, 2029 | $4.1527 | $4.1909 | $4.7761 | +2,866% |
INNOCAN PHARMA CORP. Stock (INNPF) Price Forecast for 2030
INNOCAN PHARMA CORP. Stock (INNPF) is expected to reach an average price of $4.8429 in 2030, with a high forecast of $6.2671 and a low forecast of $3.4188. This signifies an +3,359% surge from the last price of $0.14.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $5.3373 | $3.4188 | $5.6347 | +3,712% |
| February, 2030 | $4.4712 | $4.4712 | $5.1242 | +3,094% |
| March, 2030 | $3.872 | $3.5166 | $4.2273 | +2,666% |
| April, 2030 | $4.7899 | $4.8056 | $5.7928 | +3,321% |
| May, 2030 | $3.8671 | $3.8692 | $4.56 | +2,662% |
| June, 2030 | $5.4166 | $3.6144 | $5.9509 | +3,769% |
| July, 2030 | $4.2026 | $4.2137 | $5.1901 | +2,902% |
| August, 2030 | $5.7915 | $3.7122 | $6.109 | +4,037% |
| September, 2030 | $4.845 | $4.845 | $5.5583 | +3,361% |
| October, 2030 | $6.2671 | $3.81 | $6.2671 | +4,377% |
| November, 2030 | $5.1838 | $5.1995 | $5.928 | +3,603% |
| December, 2030 | $4.4208 | $3.9078 | $4.9338 | +3,058% |
0.74%
12.16%
Cap:
|
Volume (24h):